User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Manolete Partners Plc LSE:MANO London Ordinary Share GB00BYWQCY12 ORD 0.4P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 245.00 8,295 08:00:29
Bid Price Offer Price High Price Low Price Open Price
240.00 250.00 250.00 242.50 242.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 18.68 9.46 17.00 14.4 107
Last Trade Time Trade Type Trade Size Trade Price Currency
15:54:55 O 345 240.00 GBX

Manolete Partners (MANO) Latest News

More Manolete Partners News
Manolete Partners Investors    Manolete Partners Takeover Rumours

Manolete Partners (MANO) Discussions and Chat

Manolete Partners Forums and Chat

Date Time Title Posts
09/4/202121:22::: MANOLETE PARTNERS :::885
01/5/201914:14Manolete Partners at the UK Investor Show-

Add a New Thread

Manolete Partners (MANO) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Manolete Partners trades in real-time

Manolete Partners (MANO) Top Chat Posts

DateSubject
09/5/2021
09:20
Manolete Partners Daily Update: Manolete Partners Plc is listed in the General Financial sector of the London Stock Exchange with ticker MANO. The last closing price for Manolete Partners was 245p.
Manolete Partners Plc has a 4 week average price of 238p and a 12 week average price of 185p.
The 1 year high share price is 600p while the 1 year low share price is currently 180p.
There are currently 43,571,425 shares in issue and the average daily traded volume is 71,814 shares. The market capitalisation of Manolete Partners Plc is £106,749,991.25.
03/3/2021
14:43
gatehill: Although I read the presentation on their website last week I still tuned in to get the extra interpretations that the CEO gave. So why has the share price fallen today when the company has such good prospects? I regret not selling when the share price reached 600 last May, having bought at 400 the previous December but at the current price I may purchase more!
03/2/2021
07:26
jimtech: I bought in on Monday for a few reasons. This is my take... I think the previous high rating anticipated that COVID-19 related new business would come sooner than it will do. Cash flow has always been a problem and it will continue to be 'lumpy'. That's just the nature of the business. The institutions that sold made good returns on their IPO investments. They bought in requiring dividends and this would have been a drain on Manolete resources. Dividends may well now be reviewed to ease cashflow. I see Mithaq Capital as being more patient though. It is also hugely significant as they are shareholders in Burford Capital - as has previously been pointed out. So, Mithaq Capital know the sector. Insolvency litigation is an area where Burford no longer has an offering and Manolete is the UK market leader. Consequently, a merger would make sense at some point. Unless an offer is made I don't see the Manolete share price moving up for a while though. This slow down has spooked investors but it will pick up again when the UK government cease financial support of companies. Manolete Management have said that this slow-down was flagged when they released their H1 results, however, this was not clear and will have created a bit of distrust amongst investors. Consequently, it may take time to climb up again. Just my thoughts as a private investor. DYOR.
04/1/2021
16:35
maddox: Yep, the share price is starting to respond despite volume being below the average. When Miton are cleaned out then the share price recovery could be sharp - there isn't a large free float and demand could very easily outweigh supply. This is probably the last opportunity to scale-up at these prices.
18/12/2020
12:19
maddox: Hi bogman, The share price weakness is most likely due to Premier Miton selling their stake - see recent RNS. The were cornerstone investors for the IPO so have done well despite the lower current price. As Warren Buffet says “Whether we're talking about socks or stocks, I like buying quality merchandise when it is marked down.” However, the Investor psychology atm is towards Momentum investing so buying a declining chart is going against current sentiment despite the exceedingly strong fundamentals. In the long term there is a 100% correlation between a firm's share price and its underlying business performance. Regards, Maddox
23/11/2020
20:26
sirrux: 90% per Annual Report.Pass on defence is where the cartel say they don't pay out to the extent you were able to pass on the cartel's overcharge to your customers. Sounds real messy if you ask me, you could be arguing over that one for a long time.I see the general decline in Mano's share price coincides with a June 2020 EU court appeal hearing relating to the truck cartel. That may have had some sort of indirect bearing on Mano's cases. Sounds like the year end accounting discussions on the £7.1m valuation will be interesting, Mano were hopeful of an even bigger payout (that was perhaps being reflected in the pre COVID share price) but based on the dearth of news it all looks a bit iffy to me and it's now nearly 5 years after the EU ruling in 2016. Worth a few more questions I think.
17/11/2020
17:31
monkey79: LIT's accounting is clearly better than 'fair value' accounting with one expectation, markets have currently oversold MANO because of fair value accounting. For MANO's share price to half because of some dodgy report by Share Prophet is crazy. Assuming MANO case instruction remains at the same (will almost definitely increase because of COVID)then by H1 2022 they will have instructed another 252 cases, in addition to the current 224 open cases. If their duration is actually 11 months then you would envisage they would all complete by year end 2022 (some of the H2 126 cases would complete by year end). So 476 cases should complete in the next 18 months. Again MANO have only complete 305 cases since inception in 2010. Their realised gain from 2016-2020 is £27.7m (earlier years realised gain not reported). Even assuming all 305 cases realised between 2016-2020, which they did not, then the pro rata realised gain on 476 cases is £43.2m - plus the 4m realised gain from H1 2021 = £47.2m. Fair value accounting is better when market has overshot!
17/11/2020
17:29
monkey79: LIT's accounting is clearly better than 'fair value' accounting with one expectation, markets have currently oversold companies using fair value. For MANO's share price to half because of some dodgy report by Share Prophet is crazy. Assuming MANO case instruction remains at the same (will almost definitely increase because of COVID)then by H1 2022 they will have instructed another 252 cases, in addition to the current 224 open cases - . If their duration is actually 11 months then you would envisage they would all complete by year end 2022 (some of the H2 126 cases would complete by year end). So 476 cases should complete in the next 18 months. Again only 302 LIT's accounting is clearly better than 'fair value' accounting with one expectation, markets have currently oversold MANO because of fair value accounting. For MANO's share price to half because of some dodgy report by Share Prophet is crazy. Assuming MANO case instruction remains at the same (will almost definitely increase because of COVID)then by H1 2022 they will have instructed another 252 cases, in addition to the current 224 open cases. If their duration is actually 11 months then you would envisage they would all complete by year end 2022 (some of the H2 126 cases would complete by year end). So 476 cases should complete in the next 18 months. Again MANO have only complete 305 cases since inception in 2010. Their realised gain from 2016-2020 is £27.7m (earlier years realised gain not reported). Even assuming all 305 cases realised between 2016-2020, which they did not, then the pro rata realised gain on 476 cases is £43.2m - plus the 4m realised gain from H1 2021 = £47.2m. Fair value accounting is better when market has overshot!
11/11/2020
13:05
sirrux: Right, those figures and the share price 50% of what it was a year ago. Front end looks ok, all they need is to convince the market on the back end. This industry needs to sharpen up on collections - in the US they have collection managers (on behalf of the beneficiaries) who collect and distribute. They get paid for this, but it's more efficient than the claims pursuer trying to do it. Maybe they do, but I'd expect the share price to be lot higher if they were as the doubt seems to be that parties will agree settlements but will then scurry off somewhere where there's some protection against fulfilling responsibilities. I am not sure how Mano have it structured but if you've got the HMRC as a beneficiary, then it would benefit all parties to have a mutually agreed collections manager so all get paid simultaneously.
12/7/2020
11:25
xpertgreeny: The report is drivel and, as well as shorting, seems designed to promote Litigation Capital Management who have been keen to make inroads into Manolete’s sector but LCM lost their Head of Insolvency Mr Jeffries, a few months ago. Apparently he has been trying to join Manolete without success. It has the facts badly wrong on two public reported Manolete cases: 1. Stylus Sports - the report says Mano made a significant loss. That is false. Mano made a 100% cash profit. In this unusual case against a Council (which Mano won in the Supreme Court), Mano rightly negotiated a unique preferred return of 2x costs. That meant the case didn’t result in a return for the Estate but did result in a good return for shareholders. 2. Palms Palace - the report says the £4.2m judgment is worth no more than £1.5m - £1.8m. As can be seen from their latest reporting, it is held at a far lower, six figure fair value in Mano’s balance sheet. Mano discloses its 17 top value cases (above £1m judgments/settlements) and Palms Palace is simply not on that list.
11/7/2020
22:56
maddox: For heavens sake don't waste your money signing up with Share Prophets to get hold of the 'EXPLOSIVE DOSSIER' - Short Report on MANO - I have an independently sourced copy and it ain't worth the paper it isn't written on. It's a struggle reading through it with the typos, poor wording and formatting is a real mess. One of the illustrations is duplicated. It cannot decide whether to use 'mark-to-market' or 'mark-to-model'. It has the production quality to match for one of those Nigerian 419 email scams. All in all it's pretty shoddy piece of work but no matter it did its job on Friday. It's followed the Muddy Waters' short attack recipe – and has most of the ingredients – the tweet issued in advance that promises a ‘damning and incredibly detailed’ report. The report has the other Muddy Water’s ingredients, it mentions Enron, Worldcom and John Moulton takes the place of Neil Woodford. We are introduced to some shadowy chap Prof Peter Wilson that once had such a nice lunch with Manolete he Tweeted a picture or the restaurant (featured). The detail is provided from Manolete’s own report and account but is presented as original research. Well who’d know, how many actually wade through the detail of an Annual Report. The central thesis is that MANO should be valued like BUR rather than the other way around. There are a few points of interest such as the new Corporate Insolvency & Governance Act 2020 that suspends liability for trading whilst insolvent. These accurate factoids all serve to lend some credibility to the expertise of the author, whom in this case wants to remain anonymous. However, the author refers to this legislation as a 'Bill' but when a Bill is passed into legislation it becomes an 'Act' which only serves to undermine his credibility. Apparently the report is so scandalous that the author has had to hide behind the brave and righteous Tom Winnifroth of Share Prophets. No matter, the plan worked and MANO’s share price plummeted from 511p to 462p - 9.58% in a period of fifteen minutes. This is a predictable market response to the concerted shorting of the shares by ‘those in the know’ together with panicked investors selling immediately to protect their capital. Personal investors have been conditioned by the Muddy Waters short attack on Burford, rather like Pavlov’s dogs, to sell on the first whiff of controversy raised on their shareholdings. No doubt, Mr Smith in LSE’s Market Oversight Dept will not spot anything to raise his concerns. His highly calibrated 'Millennium Bug Pentagon' market surveillance system which is the scourge of market manipulators will be purring quietly un-disturbed. So, ka-ching, money made, short closed let’s look for another target. Just another day on the markets under the watchful eye of the LSE and the toothless tiger that is the FCA. Message me your email if you want a copy of this trash - it's not copyright protected. Regards Maddox
Manolete Partners share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
MANO
Manolete P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210509 20:43:03